NO20072463L - 4-hydroksytamoksifen gelformuleringer - Google Patents

4-hydroksytamoksifen gelformuleringer

Info

Publication number
NO20072463L
NO20072463L NO20072463A NO20072463A NO20072463L NO 20072463 L NO20072463 L NO 20072463L NO 20072463 A NO20072463 A NO 20072463A NO 20072463 A NO20072463 A NO 20072463A NO 20072463 L NO20072463 L NO 20072463L
Authority
NO
Norway
Prior art keywords
gel formulations
hydroxytamoxifen
hydroxytamoxifen gel
formulations
hydroxytoxifene
Prior art date
Application number
NO20072463A
Other languages
English (en)
Other versions
NO338755B1 (no
Inventor
Valerie Masini-Eteve
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/en
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of NO20072463L publication Critical patent/NO20072463L/no
Publication of NO338755B1 publication Critical patent/NO338755B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Abstract

Den foreliggende oppfinnelse angår farmasøytiske sammensetninger og geler med 4-hydroksytamoksifien, og fremgangsmåter til å anvende dem.
NO20072463A 2004-10-14 2007-05-14 4-hydroksytamoksifen gelformuleringer NO338755B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (en) 2004-10-14 2004-10-14 4-Hydroxy tamoxifen gel formulations
US63835904P 2004-12-23 2004-12-23
PCT/EP2005/011654 WO2006040196A1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations

Publications (2)

Publication Number Publication Date
NO20072463L true NO20072463L (no) 2007-05-14
NO338755B1 NO338755B1 (no) 2016-10-17

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072463A NO338755B1 (no) 2004-10-14 2007-05-14 4-hydroksytamoksifen gelformuleringer

Country Status (24)

Country Link
EP (1) EP1799201B1 (no)
JP (1) JP5047800B2 (no)
KR (1) KR101294947B1 (no)
AT (1) ATE415156T1 (no)
AU (1) AU2005293712B2 (no)
BR (1) BRPI0518139B1 (no)
CA (1) CA2582174C (no)
CY (1) CY1110499T1 (no)
DE (1) DE602005011314D1 (no)
DK (1) DK1799201T3 (no)
EA (1) EA011295B1 (no)
ES (1) ES2318563T3 (no)
GE (1) GEP20104889B (no)
HK (1) HK1103027A1 (no)
HR (1) HRP20090239T1 (no)
IL (1) IL182298A (no)
MA (1) MA28927B1 (no)
MX (1) MX2007004371A (no)
NO (1) NO338755B1 (no)
PL (1) PL1799201T3 (no)
PT (1) PT1799201E (no)
SI (1) SI1799201T1 (no)
TN (1) TNSN07139A1 (no)
WO (1) WO2006040196A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
DE60305068T2 (de) * 2002-12-18 2007-01-11 Laboratoires Besins International Behandlung von mastalgie mit 4-hydroxy-tamoxifen
US7485623B2 (en) * 2002-12-18 2009-02-03 Laboratoires Besins International Sa Reduction of breast density with 4-hydroxy tamoxifen
MXPA05010597A (es) * 2003-04-01 2006-03-09 Lab Besins Internat Prevencion y tratamiento de cancer de mama con tamoxifen 4-hidroxi.
MXPA06006834A (es) * 2003-12-15 2006-09-04 Besins Int Lab Uso de 4-hidroxitamoxifen para la preparacion de un medicamento para el tratamiento de ginecomastia.
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
DK1748770T3 (da) * 2004-03-22 2008-08-04 Besins Int Lab Behandling og forebyggelse af benign brystsygdom med 4-hydroxy-tamoxifen
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
EP1799201B1 (en) 2008-11-26
ATE415156T1 (de) 2008-12-15
BRPI0518139A (pt) 2008-10-28
NO338755B1 (no) 2016-10-17
TNSN07139A1 (en) 2008-11-21
CA2582174C (en) 2013-01-29
JP2008525316A (ja) 2008-07-17
PL1799201T3 (pl) 2009-05-29
HK1103027A1 (en) 2007-12-14
EP1799201A1 (en) 2007-06-27
EA011295B1 (ru) 2009-02-27
DE602005011314D1 (de) 2009-01-08
SI1799201T1 (sl) 2009-06-30
WO2006040196A1 (en) 2006-04-20
AU2005293712B2 (en) 2011-04-21
AU2005293712A1 (en) 2006-04-20
PT1799201E (pt) 2009-02-26
MA28927B1 (fr) 2007-10-01
EA200700834A1 (ru) 2007-10-26
IL182298A0 (en) 2007-07-24
MX2007004371A (es) 2007-06-07
DK1799201T3 (da) 2009-03-30
KR101294947B1 (ko) 2013-08-09
ES2318563T3 (es) 2009-05-01
KR20070068366A (ko) 2007-06-29
CY1110499T1 (el) 2015-04-29
GEP20104889B (en) 2010-02-10
JP5047800B2 (ja) 2012-10-10
CA2582174A1 (en) 2006-04-20
IL182298A (en) 2013-01-31
BRPI0518139B1 (pt) 2021-10-13
HRP20090239T1 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
NO20092637L (no) Fremgangsmater for behandling
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
NO20076413L (no) Multisykliske forbindelser og fremgangsmater for deres anvendelse
NO20092611L (no) Krystallinsk faststoff Rasagilin base
SE0301653D0 (sv) Novel compounds
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
DK1768490T3 (da) Systemer og fremgangsmåder til ex-vivo-organpleje
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
NO20090305L (no) Cyklosporin formuleringer
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
EA201001322A1 (ru) Вакцины против хламидиоза
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
EA200602242A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
RS20080246A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
UA87494C2 (en) Azaindoles useful as inhibitors of jak and other protein kinases
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20065791L (no) Asyklovir-formuleringer
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов
NO20072463L (no) 4-hydroksytamoksifen gelformuleringer
SE0300457D0 (sv) Novel compounds
NO20091771L (no) Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: LABORATOIRES BESINS INTERNATIONAL, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL, LU